• Bone Health
  • Immunology
  • Hematology
  • Respiratory
  • Dermatology
  • Diabetes
  • Gastroenterology
  • Neurology
  • Oncology
  • Ophthalmology
  • Rare Disease
  • Rheumatology

The Top 5 Biosimilar Articles for the Week of May 20

News
Video

Here are the top 5 biosimilar articles for the week of May 20, 2024.

Number 5: At the Festival of Biologics USA, panelists stressed the need for patient-centered communication and education to boost comfort with biosimilars, emphasizing consistent support from health care providers despite restrictive payer policies.

Number 4: Because of differences in how national authorities that manage drug pricing and reimbursement view health technology assessment (HTA) tools for biosimilars, there’s an urgent need for agencies to issue clear guidance on when and how to conduct HTAs for biosimilars, according to a recent report.

Number 3: The FDA approved the first 2 biosimilars referencing Eylea (aflibercept)—Yesafili (aflibercept-jbvf) and Opuviz (aflibercept-yszy)—for the treatment of ophthalmic conditions.

Number 2: In Canada, a study on patients with inflammatory bowel disease (IBD) switching to infliximab or adalimumab biosimilars found no change in clinical remission or antidrug antibodies after 24 weeks, but 13% experienced the nocebo effect, leading to one-fifth discontinuing therapy.

Number 1: Two posters from the Academy of Managed Care Pharmacy’s annual meeting provided hope that despite low uptake so far, adalimumab biosimilars can deliver on the promise of comparable safety and efficacy with the originator in multiple disease states as well as cost savings.

To read all of these articles and more, visit centerforbiosimilars.com.

Related Videos
Here are the top 5 biosimilar articles for the week of June 17, 2024.
Here are the top 5 biosimilar articles for the week of June 10, 2024.
The Top 5 Biosimilar Articles of the Week.
Here are the top 5 biosimilar articles for the week of May 27, 2024.
Here are the top 5 biosimilar articles for the week of May 13, 2024.
The Top 5 Center for Biosimilars Articles for the Week of May 6, 2024.
Here are the top 5 biosimilar articles for the week of April 29, 2024.
© 2024 MJH Life Sciences

All rights reserved.